tiprankstipranks
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
Holding BMRN?
Track your performance easily

BioMarin Pharmaceutical (BMRN) Income Statement

1,985 Followers

BioMarin Pharmaceutical Income Statement

Last quarter (Q3 2024), BioMarin Pharmaceutical's total revenue was $745.74M, an increase of 28.28% from the same quarter last year. In Q3, BioMarin Pharmaceutical's net income was $106.08M. See BioMarin Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.75B$ 2.42B$ 2.10B$ 1.85B$ 1.86B$ 1.70B
Cost of Revenue
$ 570.65M$ 514.85M$ 483.67M$ 470.51M$ 524.27M$ 359.47M
Gross Profit
$ 2.17B$ 1.90B$ 1.61B$ 1.38B$ 1.34B$ 1.34B
Operating Expense
$ 1.78B$ 1.75B$ 1.57B$ 1.38B$ 1.36B$ 1.75B
Operating Income
$ 337.03M$ 158.10M$ 149.56M$ -82.34M$ -36.77M$ -100.46M
Net Non Operating Interest Income Expense
$ 65.60M$ 41.00M$ 2.06M$ -4.86M$ -12.70M$ -712.00K
Other Income Expense
$ -33.19M$ -10.54M$ 101.55M-$ -59.49M$ -24.41M
Pretax Income
$ 391.45M$ 188.56M$ 149.58M$ -75.35M$ -42.32M$ -94.81M
Tax Provision
$ 69.16M$ 20.92M$ 8.02M$ -11.27M$ -903.03M$ -70.96M
Earnings From Equity Interest Net Of Tax
----$ -6.00K$ -587.00K
Net Income Common Stockholders
$ 325.87M$ 167.65M$ 141.56M$ -64.08M$ 854.03M$ 124.37M
Basic EPS
$ 1.70$ 0.89$ 0.76$ -0.35$ 4.75$ -0.13
Diluted EPS
$ 1.66$ 0.87$ 0.75$ -0.35$ 4.53$ -0.13
Basic Average Shares
$ 757.91M$ 187.83M$ 185.27M$ 182.85M$ 180.80M$ 179.04M
Diluted Average Shares
$ 782.76M$ 191.59M$ 188.96M$ 182.85M$ 191.68M$ 179.04M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 2.81B$ 2.26B$ 2.05B$ 1.85B$ 1.88B$ 2.11B
Net Income From Continuing And Discontinued Operation
$ 322.29M$ 167.65M$ 141.56M$ -64.08M$ 854.03M$ -23.85M
Normalized Income
$ 675.46M$ 715.03M--$ -1.00B$ 168.69M
Interest Expense
------
EBIT
$ 400.50M$ 205.30M$ 164.95M$ -60.61M$ -21.52M$ -71.35M
EBITDA
$ 504.39M$ 309.69M$ 266.92M$ 47.43M$ 83.66M$ 45.91M
Currency in USD

BioMarin Pharmaceutical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis